| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,087,000 | 3,010,000 | 3,481,000 | 3,810,200 | | Cost of Revenue | 2,196,000 | 2,135,000 | 2,442,000 | 2,616,800 | | | Gross Profit | 891,000 | 875,000 | 1,039,000 | 1,193,400 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 271,000 | 342,000 | 319,000 | 326,400 | | Non Recurring | 19,000 | 147,000 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 601,000 | 386,000 | 720,000 | 867,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (9,000) | (36,000) | (34,000) | 18,800 | | Earnings Before Interest And Taxes | 593,000 | 366,000 | 714,000 | 891,000 | | Interest Expense | 14,000 | 13,000 | 13,000 | 14,500 | | Income Before Tax | 579,000 | 353,000 | 701,000 | 876,500 | | Income Tax Expense | 192,000 | 131,000 | 228,000 | 286,100 | | Minority Interest | (7,000) |
-
|
-
| (5,400) | | | | Net Income From Continuing Ops | 425,000 | 222,000 | 473,000 | 585,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 380,000 | 222,000 | 473,000 | 585,000 | | Preferred Stock And Other Adjustments | 5,000 | (2,000) | (3,000) |
-
| | | Net Income Applicable To Common Shares | $385,000 | $220,000 | $470,000 | $585,000 |
|
0.36% Nasdaq 
0.31%
Income Statement
